IFN-gamma release assays in tuberculosis management in selected high-risk populations (Q37418061)

20 August 2017

1 reference

title

IFN-gamma release assays in tuberculosis management in selected high-risk populations (English)

1 reference

20 August 2017

0 references

0 references

Marialuisa Bocchino

1

1 reference

20 August 2017

Barbara Bellofiore

2

1 reference

20 August 2017

Alessandro Matarese

3

1 reference

20 August 2017

Domenico Galati

4

1 reference

20 August 2017

Alessandro Sanduzzi

5

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

165-177

1 reference

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Mechanisms of latency in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Diagnosis and treatment of tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

T cell-based diagnosis of childhood tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

A contact investigation of the transmission of Mycobacterium tuberculosis from a nurse working in a newborn nursery and maternity ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Reproducibility of QuantiFERON-TB gold in-tube assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

T-Cell-Based Diagnosis of Neonatal Multidrug-Resistant Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Enzyme-Linked Immunospot Assay Responses to Early Secretory Antigenic Target 6, Culture Filtrate Protein 10, and Purified Protein Derivative among Children with Tuberculosis: Implications for Diagnosis and Monitoring of Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

Use of a T-cell interferon- release assay for the diagnosis of tuberculous pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.2.165

21 January 2018

Identifiers

DOI

10.1586/14737159.9.2.165

1 reference

20 August 2017

1 reference